KAIROS PHARMA LTD
KAPA·48301N104·US·equity·Healthcare - Biotechnology-13D/G
KAPA (KAIROS PHARMA LTD) is held by 6 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($62,210), Aptus Capital Advisors, LLC ($24,756), TWO SIGMA INVESTMENTS, LP ($22,105). Net institutional sentiment: Bearish.
6
Holders
Avg rating(1 Elite)
$122,561
Total Value
30% (12)
Fund Consensus
3 buying - 7 selling
Smart Money Verdict38Weak MomentumConfirmed
Get 5 free verdicts/month - sign up in 10 seconds
See how KAPA's score breaks down across 4 SEC sources
Held by 6 funds
1 elite
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Increased | 111,290(+52.8%) | $62,210 | 0.0% | -45.36% | 20 | |
Unchanged | 44,286 | $24,756 | 0.0% | -47.83% | 0 | |
Decreased | 39,543(-57.9%) | $22,105 | 0.0% | -46.94% | 0 | |
Unchanged | 24,100 | $13,472 | 0.0% | -57.14% | 0 | |
Increased | 21,575(+1.2%) | $12 | 0.0% | -31.34% | 8 | |
New | 10 | $6 | 0.0% | -22.58% | 17 | |
Exited | 0(-100.0%) | $34,431 | 0.0% | -10.45% | 0 | |
Exited | 0(-100.0%) | $10,751 | 0.0% | -11.43% | 0 | |
Exited | 0(-100.0%) | $9,261 | 0.0% | -11.43% | 0 | |
Exited | 0(-100.0%) | $228,434 | 0.0% | -11.43% | 0 | |
Exited | 0(-100.0%) | $95 | 0.0% | -43.07% | 0 | |
Exited | 0(-100.0%) | $14,000 | 0.0% | -11.43% | 0 |
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
410 holders · $577.8B
UNHUNITEDHEALTH GROUP INC409 holders · $155.8B
JNJJOHNSON & JOHNSON391 holders · $327.3B
DHRDANAHER CORP DEL388 holders · $82.5B
ISRGINTUITIVE SURGICAL INC388 holders · $102.1B
TMOTHERMO FISHER SCIENTIFIC INC387 holders · $127.1B
BSXBOSTON SCIENTIFIC CORP386 holders · $67.5B
MRKMERCK & CO INC381 holders · $175.6B
ABBVABBVIE INC378 holders · $212.3B
ABTABBOTT LABORATORIES376 holders · $108.9B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer